Pfizer Inc (PFE)
$24.27+2.51%
Spriggl Score: Moderate— sign in to explore; full breakdown with Premium
Last 30 trading days
Spriggl AI Verdict
“High-yield transitional pharma at 9x forward earnings; CFO change adds uncertainty ahead of patent-cliff onset.”
Sign up free to read the full investment thesis, bull case, bear case and what to watch.
About Pfizer Inc
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovas…
- Sector:
- Healthcare
- Industry:
- Drug Manufacturers - General
- Market Cap:
- $147.7B
Recent dividends
- 8 May 2026$0.43
- 23 Jan 2026$0.43
- 7 Nov 2025$0.43
Get the full Spriggl analysis — free
A free Spriggl account gets you the screener, a watchlist, AI verdicts and a free full report every day — across Pfizer Inc and 1,500+ UK and US stocks. The full score breakdown and AI analysis come with Premium.
Start free